Back

Women with fibromyalgia: Insights into behavioral and brain imaging

Elkana, O.; Beheshti, I.

2024-09-16 pain medicine
10.1101/2024.09.15.24313716
Show abstract

Fibromyalgia (FM) is a chronic condition marked by widespread pain, fatigue, sleep problems, cognitive decline, and other symptoms. Despite extensive research, the pathophysiology of FM remains poorly understood, complicating diagnosis and treatment, which often relies on self-report questionnaires. This study explored structural and functional brain changes in women with FM, identified potential biomarkers, and examined their relationship with FM severity. MRI data from 33 female FM patients and 33 matched healthy controls were utilized, focusing on T1-weighted MRI and resting-state fMRI scans. Functional connectivity (FC) analysis was performed using a machine learning framework to differentiate FM patients from healthy controls and predict FM symptom severity. No significant differences were found in brain structural features, such as gray matter volume, white matter volume, deformation-based morphometry, and cortical thickness. However, significant differences in FC were observed between FM patients and healthy controls, particularly in the default mode network (DMN), somatomotor network (SMN), visual network (VIS), and dorsal attention network (DAN). The FC metrics were significantly associated with FM severity. Our prediction model differentiated FM patients from healthy controls with an area under the curve of 0.65. FC measures accurately estimated FM symptom severities with a significant correlation (r = 0.45, p = 0.007). Functional connections in the DMN, VIS, and DAN were crucial in determining FM severity. These findings suggest that integrating brain FC measurements could serve as valuable biomarkers for early detection of FM and predicting FM symptom severity, improving diagnostic accuracy and facilitating the development of targeted therapeutic strategies.

Matching journals

1
Frontiers in Human Neuroscience
Frontiers Media SA · based on 11 published papers
#1
264× avg
2
Pain
Ovid Technologies (Wolters Kluwer Health) · based on 15 published papers
Top 0.2%
136× avg
3
Scientific Reports
Springer Science and Business Media LLC · based on 701 published papers
Top 10%
2.5× avg
4
Human Brain Mapping
Wiley · based on 53 published papers
Top 0.9%
25× avg
5
PLOS ONE
Public Library of Science (PLoS) · based on 1737 published papers
Top 60%
6.9%
6
The Journal of Pain
Elsevier BV · based on 11 published papers
Top 0.3%
89× avg
7
Neuroscience & Biobehavioral Reviews
Elsevier BV · based on 19 published papers
Top 0.4%
26× avg
8
Frontiers in Immunology
Frontiers Media SA · based on 140 published papers
Top 3%
8.3× avg
9
Frontiers in Neuroscience
Frontiers Media SA · based on 29 published papers
Top 1.0%
17× avg
10
Science Advances
American Association for the Advancement of Science (AAAS) · based on 52 published papers
Top 0.7%
13× avg
11
Brain
Oxford University Press (OUP) · based on 69 published papers
Top 5%
4.8× avg
12
BMC Neurology
Springer Science and Business Media LLC · based on 11 published papers
Top 2%
17× avg
13
Brain Sciences
MDPI AG · based on 19 published papers
Top 0.8%
18× avg
14
Cerebral Cortex
Oxford University Press (OUP) · based on 15 published papers
Top 0.8%
27× avg
15
Blood Advances
American Society of Hematology · based on 16 published papers
Top 0.9%
16× avg
16
eLife
eLife Sciences Publications, Ltd · based on 262 published papers
Top 32%
0.7%
17
Clinical Pharmacology & Therapeutics
Wiley · based on 19 published papers
Top 2%
6.0× avg
18
Molecular Psychiatry
Springer Science and Business Media LLC · based on 84 published papers
Top 6%
2.7× avg